Chargement en cours...
Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles
Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone. In this article, outcomes in relation to bone homeostasis, bone mineral density (BMD), and osteopeni...
Enregistré dans:
| Publié dans: | Drugs Context |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioExcel Publishing Ltd
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337603/ https://ncbi.nlm.nih.gov/pubmed/32670383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-3-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|